Navigation Links
GW Pharmaceuticals Commences Phase 1 Clinical Trial of GWP42006 as a Potential Treatment for Epilepsy
Date:9/17/2013

LONDON, Sept. 18, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW") announced today it has commenced a Phase 1 clinical trial of product candidate GWP42006 for the treatment of epilepsy.  

Over the last five years, GW has conducted an extensive pre-clinical cannabinoid research program in the field of epilepsy in collaboration with the University of Reading in the United Kingdom. This research has led to the emergence of a number of promising cannabinoid therapeutic candidates showing anti-epileptic effects. GWP42006, one of the most promising of those candidates, is a non-psychoactive cannabinoid extracted from specific chemotypes of the cannabis plant which has shown the ability to treat seizures in pre-clinical models of epilepsy with significantly fewer side effects than currently approved anti-epileptic drugs1.

"We are pleased to have advanced GWP42006 to first dose in man, a significant milestone in the development of this novel product candidate. The decision to progress into Phase 1 follows several years of highly promising pre-clinical research," stated Dr. Stephen Wright, Director of Research and Development at GW. "We believe that GWP42006 has the potential to become an important advance in the treatment of epilepsy, a condition for which there remains a substantial unmet medical need."

Dr. Ben Whalley, Senior Lecturer in Pharmacology at the Reading School of Pharmacy, said, "Our research collaboration with GW over the last several years has shown that GWP42006 not only exerts significant anticonvulsant effects in a wide range of preclinical models of seizure and epilepsy but is also better tolerated compared to existing anti-epileptic drugs. It is also noteworthy that GWP42006 appears to employ a different mechanism of action to currently available anti-epileptic
'/>"/>

SOURCE GW Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Teva Pharmaceuticals Donates to the National Multiple Sclerosis Society in recognition of Jack Osbourne as He Competes on "Dancing with the Stars"
2. JHP Pharmaceuticals Enters Agreement to Produce Unique Late Stage Ophthalmic Product
3. Actinium Pharmaceuticals Appoints Kaushik J. Dave, Ph.D., MBA As President, Chief Executive Officer And Director
4. Frost & Sullivan Lauds Adcock Ingrams Capability to Innovatively Cater to the Dynamic Needs of Emerging Pharmaceuticals Markets
5. Dr. David Hangauer, Chief Scientific Officer and Co-Founder, commits his career to Kinex Pharmaceuticals
6. Access Pharmaceuticals Awarded Second European Patent for MuGard
7. Cardioxyl Pharmaceuticals Appoints Shi Yin Foo, M.D., Ph.D., As Chief Medical Officer
8. Caldera Pharmaceuticals Announces Closing of Financing
9. HedgePath Pharmaceuticals Enters into Key Collaboration with Mayne Pharma
10. Boehringer Ingelheim Expands Investigation of Interferon-free Hepatitis C Treatment Regimens to Reach More Patient Types through Presidio Pharmaceuticals Clinical Collaboration
11. Roche and Inovio Pharmaceuticals partner on Inovios prostate cancer and hepatitis B immunotherapy products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015 The controversy surrounding the ... and myomectomies (procedures to remove uterine fibroids) continues, ... is investigating Johnson & Johnson,s Ethicon, Inc. unit, ... devices. According to the report published by The ... the FBI is trying to determine what the ...
(Date:5/28/2015)... May 28, 2015 Isis Pharmaceuticals, Inc. (NASDAQ: ... Therapeutics WebcastWhen: , Thursday, June 4 at 1:00 p.m. ... , Live on the Internet.  Simply log onto our ... during the live event, a replay of the webcast ... www.isispharm.com . ABOUT ISIS PHARMACEUTICALS, INC. Isis ...
(Date:5/28/2015)... May 28, 2015   Mast Therapeutics, Inc. ... leveraging its molecular adhesion and sealant technology (MAST) ... disease, heart failure, and arterial disease, today announced ... Company,s Board of Directors. Mr. Lief made this ... given his role as President and Chief Executive ...
Breaking Medicine Technology:Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 3Webcast Alert: Akcea Therapeutics Conference Call 2Webcast Alert: Akcea Therapeutics Conference Call 3Mast Therapeutics Announces Change In Board Of Directors 2Mast Therapeutics Announces Change In Board Of Directors 3Mast Therapeutics Announces Change In Board Of Directors 4
... SAN DIEGO, Feb. 16, 2012  Cardium Therapeutics (NYSE Amex: ... completed the previously announced sale of 17,857,143 shares of ... gross proceeds of approximately $5.0 million, before deducting placement ... and accredited investors participating in the offering purchased the ...
... Bionovo, Inc. (OTC Link Platform: BNVI.PK) a pharmaceutical company ... effective treatments for women,s health and cancer, announced today ... February 21, 2012 at 1:30 PM PST to discuss ... 31, 2011. (Logo:  http://photos.prnewswire.com/prnh/20111110/SF04662LOGO ) ...
Cached Medicine Technology:Cardium Announces Closing of $5.0 Million Equity Financing 2Cardium Announces Closing of $5.0 Million Equity Financing 3
(Date:5/28/2015)... Success Strategies for Biosimilars Approval:, ... Webinar**, June 23, 2015 — 11:00 a.m. – ... June 23, 2015, FDAnews is offering the combined ... attorneys from the international law firm Duane Morris ... A Roadmap to the 351(k) Application Process. , ...
(Date:5/28/2015)... May 28, 2015 The Boys & Girls ... from Horizon Blue Cross Blue Shield of New Jersey (Horizon ... Gulbis, the club can receive much more support as play ... , A former Boys & Girls Club member and volunteer ... California, Ms. Gulbis has accepted the Horizon Blue Cross Blue ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 AMVETS leaders ... grand prize winner Robert Davis of Newark, Del. AMVETS ... congratulate him on winning the $10,000 sweepstakes grand prize. ... over 100,000 entries from around the country for prizes ... drawing took place on May 21 at the AMVETS ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 As the summer ... to keep cool. It’s important to make safety a top ... sharing some swimming tips. , According to the Centers for ... the United States, not including boating incidents. Additionally, the National ... for children ages 1 to 4. , Amica is ...
(Date:5/28/2015)... 2015 Altima Technologies, Inc., the ... for documenting and diagramming data center assets and ... following product lines: , Manufacturer / Device ... Products N-Series TeraFrame Cabinet, Middle Atlantic Products RSH ... Systems ForeRunner, Marantz America MM Series, Extron Electronics ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 3Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 2Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 3Health News:AMVETS Announces Summer Sweepstakes Winners 2Health News:Splash! Amica Shares 6 Swimming Safety Tips 2Health News:NetZoom™ Visio® Stencil Library Updates for EMC, Cisco, and Chatsworth Products 2
... ... agreements, LOS ... distributor of at-home testing diagnostics,for the chronically ill, life-saving prescription drugs ... results for the first quarter period-ended March 31, 2008. Recent,highlights include:, ...
... Dr. Julie Gerberding to give keynote speech June 9 ... Gerberding,director of the U.S. Centers for Disease Control and ... health during a,keynote address at the American Water Works ... 9, in Atlanta, Georgia., As one of the ...
... to remain in Upstate New York, FLORIDA, N.Y., ... innovation in infant nutrition for more than 75 years ... nutrition in its,wide variety of products will be enhanced ... foot infant food manufacturing facility,scheduled to open in fall ...
... Who Suffered from a ,Drive-Through, Mastectomy and Signed, Lifetime,s Petition, Testifies ... ... Subcommittee Today, NEW YORK, May 21 On behalf of ... Health Subcommittee for holding the first ever hearing on the,bipartisan Breast ...
... returns to Cape Cod home while doctors determine treatment plans ... -- Sen. Edward M. Kennedy walked out of Massachusetts General ... revealed that he has a malignant brain tumor. , With ... the spot where doctors had performed a biopsy that led ...
... At the Renewal Weekend workshop in May, Deepak Chopra, M.D. and David, Simon, ... ... mind., NEW YORK, May 21 This ... Renewal Weekend, where renowned,authors, physicians, and Chopra Center co-founders, Deepak Chopra & David,Simon, ...
Cached Medicine News:Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 2Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 4Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 5Health News:CDC Director to Address Public Health and Drinking Water at ACE08 2Health News:Hero/Beech-Nut's Role as an Innovation Leader Strengthened with New Infant Food Manufacturing Facility 2Health News:Hero/Beech-Nut's Role as an Innovation Leader Strengthened with New Infant Food Manufacturing Facility 3Health News:After Collecting 22 Million Petition Signatures on myLifetime.com, Bipartisan Breast Cancer Patient Protection Act Gets First Congressional Hearing in 12 Years 2Health News:Ted Kennedy Released From Hospital 2Health News:Ted Kennedy Released From Hospital 3Health News:Ted Kennedy Released From Hospital 4Health News:Ted Kennedy Released From Hospital 5Health News:The Chopra Center Co-founders Bring Mind-Body Healing to New York City 2
Heparin-Platelet Factor 4 Induced Antibody...
Multi-constituent normal and abnormal plasma controls for routine and specialty assays performed on the STA© family of hemostasis analyzers....
ASO Calibrator (Latex-Enhanced Immunoturbidimetric)...
CRP Calibrator...
Medicine Products: